Matt Pauls

(Mr. Matthew Pauls J.D.)

Currently holds positions in Strongbridge Biopharma plc, Zyla Life Sciences and Savara Inc

Positions

Position Company Period
Chief Executive Officer, Director Strongbridge Biopharma plc Aug. 1, 2014 -
Director Zyla Life Sciences Jan. 31, 2019 -
Independent Director Savara Inc Nov. 2, 2015 -
Chief Commercial Officer Insmed Inc April 1, 2013 - Dec. 1, 2014
Matt Pauls's trades of Soleno Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-03-31 2025-03-28 S Sale
5,937 -47.7%
71.55
USD 424,797
5,937 -47.7% 71.55 USD 424,797
2024-12-16 2024-12-16 S Sale
54,702 -3.4%
3.31
USD 180,828
54,702 -3.4% 3.31 USD 180,828
2023-12-29 2023-12-28 S Sale
84,000 -6.1%
4.71
USD 395,900
84,000 -6.1% 4.71 USD 395,900
2021-12-08 2021-12-08 B Purchase
6,500 +1.7%
1.06
USD 6,889
6,500 +1.7% 1.06 USD 6,889
2021-12-02 2021-12-02 B Purchase
10,000 +2.7%
1.10
USD 10,954
10,000 +2.7% 1.10 USD 10,954
2021-11-22 2021-11-19 B Purchase
2,150 +0.6%
1.07
USD 2,290
2,150 +0.6% 1.07 USD 2,290
2021-11-22 2021-11-19 B Purchase
10,000 +2.8%
1.11
USD 11,100
10,000 +2.8% 1.11 USD 11,100
2021-11-22 2021-11-18 B Purchase
10,000 +2.9%
1.10
USD 11,000
10,000 +2.9% 1.10 USD 11,000
2021-04-19 2021-04-19 PP Planned purchase
27,400 +9.8%
1.82
USD 49,871
27,400 +9.8% 1.82 USD 49,871
2021-03-22 2021-03-22 PP Planned purchase
24,100 +9.4%
2.07
USD 49,938
24,100 +9.4% 2.07 USD 49,938
2021-02-23 2021-02-22 PP Planned purchase
28,700 +12.6%
1.74
USD 50,038
28,700 +12.6% 1.74 USD 50,038
// ... existing code ... // ... rest of the file ...